Evidence map›Paper›PMID 9032473›Full record

ArticleThe Biochemical journal1997

Accumulation of glucosaminyl(acyl)phosphatidylinositol in an S3 HeLa subline expressing normal dolicholphosphomannose synthase activity.

D Sevlever, D Schiemann, J Guidubaldi, M E Medof, T L Rosenberry

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

D SevleverDepartment of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, U.S.A.
D Schiemann
J Guidubaldi
M E Medof
T L Rosenberry
Case Western Reserve University · US

Funding

STRUCTURE AND FUNCTION OF GLYCOINOSITOLP01DK038181 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI TARTAKOFF, ALAN MICHAEL · 1987 to 1996
–
NIDDK NIH HHS DK38181
6 · The paper itself

Abstract

Glucosaminyl(acyl)phosphatidylinositol [GlcN(acyl)PI], the third intermediate in the mammalian glycosylphosphatidylinositol (GPI) anchor pathway, is undetectable in most cells. This intermediate was previously shown to accumulate, however, in murine lymphoma mutant E and in yeast mutant dpm1, both of which lack dolicholphosphomannose synthase activity. Here we report that a mammalian HeLa S3 subline, denoted D, produces large amounts of GlcN(acyl)PI. The level of GlcN(acyl)PI in this subline is twice that in the murine lymphoma mutant E and 4 times that in the parental S3 line. This HeLa D subline differs from the previously reported mutants that accumulate GlcN(acyl)PI because no defects in the synthesis or utilization of dolicholphosphomannose were found. Kinetic analysis indicated that in this HeLa subline there is an increased rate of synthesis of GlcN(acyl)PI, whereas the rate of metabolism for this GPI is comparable to that in wild-type cells. Furthermore, HeLa D cells accumulate GlcN(acyl)PI without a block in the synthesis of the downstream mannosylated GPI anchor precursors and GPI-anchored proteins. These findings might be relevant for understanding the regulation of the GPI pathway.

Indexed as

Chromatography, GelChromatography, Thin LayerElectrophoresis, Polyacrylamide GelGlucosamineGlycosylphosphatidylinositolsHeLa CellsHumansInositolKineticsMannosidesMannosyltransferasesMicroscopy, Phase-ContrastOligosaccharidesPhosphatidylinositolsRadioimmunoassaydolichyl-phosphate beta-D-mannosyltransferaseGlucosamineGlycosylphosphatidylinositolsInositolMannosidesMannosyltransferasesOligosaccharidesPhosphatidylinositols

Identifiers

PMID9032473
PMCPMC1218142
OpenAlexW1790120461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.